New drug combo shows promise for aggressive blood cancer
NCT ID NCT04546620
First seen May 03, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study looks at whether adding the drug acalabrutinib to standard chemotherapy (R-CHOP) helps people with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL). About 450 adults with untreated DLBCL will receive one round of standard chemo, then two-thirds will also take acalabrutinib pills for five more cycles. The main goal is to see if the combination delays the cancer from coming back or getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke's Hospital
Cambridge, United Kingdom
-
Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
-
Chase Farm and Barnet Hospitals
London, United Kingdom
-
Churchill Hospital
Oxford, United Kingdom
-
Colchester General Hospital
Colchester, Essex, United Kingdom
-
Derriford Hospital
Plymouth, United Kingdom
-
East Kent Hospitals NHS Foundation Trust
Canterbury, Kent, United Kingdom
-
Freeman Hospital
Newcastle, United Kingdom
-
Ipswich Hospital
Ipswich, United Kingdom
-
Leicester Royal Infirmary
Leicester, United Kingdom
-
Lewisham and Greenwich NHS Trust
London, United Kingdom
-
Maidstone Hospital
Maidstone, United Kingdom
-
Milton Keynes University Hospital
Milton Keynes, United Kingdom
-
Monklands Hospital
Airdrie, United Kingdom
-
Norfolk and Norwich University Hospital
Norwich, United Kingdom
-
Nottingham City Hospital
Nottingham, United Kingdom
-
Queen Alexandra Hospital
Portsmouth, United Kingdom
-
Queen's Hospital
Romford, United Kingdom
-
Queens Hospital
Burton-on-Trent, United Kingdom
-
Royal Cornwall Hospital
Truro, United Kingdom
-
Royal Derby Hospital
Derby, United Kingdom
-
Royal Devon and Exeter Hospital
Exeter, United Kingdom
-
Royal Oldham Hospital
Oldham, United Kingdom
-
Royal Stoke University Hospital
Stoke-on-Trent, United Kingdom
-
Singleton Hospital
Swansea, United Kingdom
-
Southampton General Hospital
Southampton, United Kingdom
-
St James Hospital
Leeds, United Kingdom
-
The Christie Hospital
Manchester, United Kingdom
-
Torbay Hospital
Torquay, United Kingdom
-
University College London Hospital
London, United Kingdom
-
University Hospital Dorset NHS Foundation Trust (Bournemouth and Poole Hospitals)
Bournemouth, United Kingdom
-
Victoria Hospital
Blackpool, United Kingdom
-
Worthing and St Richards Hospitals
Worthing, United Kingdom
Conditions
Explore the condition pages connected to this study.